Clal Biotechnology Industries (CBI) is Israel’s biotechnology investment hub traded on the Tel Aviv stock exchange (TASE: CBI).
CBI is focused on identifying and supporting promising innovative ventures, developing proprietary solutions and addressing unmet medical needs with significant market potential.
Ofer Gonen
[email protected]
132 Menachem Begin Street, Tel Aviv, Israel
+972525902266
http://cbi.co.il/
How Do We Operate?
With offices in Tel-Aviv and Boston, we provide our portfolio companies access to the global biotechnology industry.
Based on top Israeli science, our portfolio companies ranging from seed to maturity, both public and private. We apply diverse models of strategic cooperation, providing hands-on leadership and guidance.
Empowering Life Sciences Solutions
CBI’s investments range from biotech and pharma to diagnostics and medical devices.
Our team maximizes the value of existing investments, contributes to the development of investee companies and finds new investments and business opportunities in Israel and the United States with high potential return globally.